Here 24/7 Wall St. has included a calendar of some of the biggest companies expecting clinical trial and U.S. Food and Drug Administration (FDA) updates in September.
Pfizer shares slipped on Monday despite the company posting positive results from a late-stage tafamidis trial.
Chris Lange The August 15 short interest data have been compared with the previous figures, and short interest in these selected pharmaceutical stocks was mixed.
The top analyst upgrades, downgrades and initiations seen on Thursday include Aetna, Analog Devices, Lowe's, Merck, Pfizer, Plug Power, Qualcomm and Target.
Big Pharma is looking good for investors in the second half of 2018. That's the message from the research team at Bank of America Merrill Lynch.
The FDA is extending the expiration dates for certain EpiPens in light of the national shortage ahead of the back-to-school season.
Caterpillar, Apple, Pfizer, and Cisco were Friday's top-gaining Dow stocks.
The latest monthly Merrill Lynch RIC Report is quite favorable on the health care sector as an opportunity for investors. Here we identify some of the top health care picks.
Merrill Lynch now recommends these five outstanding dividend-paying U.S. stocks with solid upside potential.
The July 31 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks increased.
The Dow is set to finish essentially flat Wednesday, with Disney and Caterpillar weighing on the index as Pfizer and McDonald's do the heavy lifting.
Disney, DowDuPont, Pfizer, and Cisco Systems led the Dow higher Monday.
IBM, Pfizer, Walmart, and Coca-Cola were among the leading gainers on the Dow index Friday.
3M, Pfizer, Caterpillar, and United Technologies posted the best gains among the Dow 30 stocks Tuesday.
Pfizer released better-than-expected second-quarter financial results before the markets opened on Tuesday.
Chris Lange 
